STUDY REPORT ReY01, clinical trial on Vapronol T6® finalized

Nanox Nutriceuticals finalized an extensive clinical trial in which the activity of Vapronol T6® was compared vs Placebo. The results of this study are even above our expectations and proved in a convincing that Vapronol T6® is a true ergogenic complex, supporting the sporter in controlling stress, increasing endurance and muscle protection.

Main result demonstrated:

Increase in mean muscular power (dynamometric evaluation) from 9,16 to 21,50 in men and from 6,65 to 18,13 in women

 Normalisation of stress (SAS - anxiety rating) from 3,65 to 1,25 in both men and women

Normalisation of free radicals, protection against muscular damage and oxidative stress (CAT - Total antioxidant capacity) from 681,82 to 294,81 in men and from 646,35 to 314,31 in women

All results were all highly statistically valuable. The complete study report will be edited in a few weeks.